LETROZOLE DEXCEL

Riik: Iisrael

keel: inglise

Allikas: Ministry of Health

Toimeaine:

LETROZOLE

Saadav alates:

DEXCEL LTD, ISRAEL

ATC kood:

L02BG04

Ravimvorm:

FILM COATED TABLETS

Koostis:

LETROZOLE 2.5 MG

Manustamisviis:

PER OS

Retsepti tüüp:

Required

Valmistatud:

HAUPT PHARMA MUNSTER GmbH, GERMANY

Terapeutiline rühm:

LETROZOLE

Terapeutiline ala:

LETROZOLE

Näidustused:

Letrozole - Dexcel tablets is indicated for first-line treatment in postmenopausal women with hormone receptor positive or in whome hormone receptor status cannot be determined locally advanced or metastatic breast cancer. Letrozole - Dexcel is also indicated for the treatment of advanced breast cancer in postmenopausal women with disease progression following antiestrogen therapy. Extended adjuvant treatment of early breast cancer in post menopausal women who have received prior standard adjuvant tamoxifen therapy. Adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer.

Loa andmise kuupäev:

2016-02-29